In 95% of 41 AML samples, AML cells from the CD34+TMIGD2+ subset expressed at least one of the CD45RA, CD123 and IL1RAP markers (Supplementary Fig. 1e). This evidence concerns the gene IL1RAP and acute myeloid leukemia.